
ACETAZOLAMIDE AND MEXILETINE
Large changes in urinary pH caused by the concurrent use of alkalinising drugs such as acetazolamide can, in some patients, have a marked effect on the plasma levels of mexiletine.
The effect does not appear to be predictable. The manufacturer of mexiletine recommends that concurrent use should be avoided.
The effect does not appear to be predictable. The manufacturer of mexiletine recommends that concurrent use should be avoided.